This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

Orion Biotech Opportunities (ORIA) Stock Overview

Orion Biotech Opportunities Corp. does not have significant operations. More details

ORIA fundamental analysis
Snowflake Score
Valuation	2/6
Future Growth	0/6
Past Performance	2/6
Financial Health	3/6
Dividends	0/6

Rewards

Price-To-Earnings ratio (29.2x) is below the Capital Markets industry average (29.5x)

Became profitable this year

Risk Analysis

Makes less than USD$1m in revenue ($0)

Negative shareholders equity

Less than 3 years of financial data is available

ORIA Community Fair Values

Create Narrative

See what others think this stock is worth. Follow their fair value or set your own to get alerts.

NEW435,612 members

Join community and earn perks

Gain real feedbackFrom our editorial team, personally. Not silence.

Grow your followingReal investors. The kind who actually invest, not scroll past.

Unlock free accessFree premium subscription for consistent and quality authors.

Learn more Create Narrative

435,612 investors already sharing narratives

View all narratives

Orion Biotech Opportunities Corp. Competitors

Price History & Performance

Summary of share price highs, lows and changes for Orion Biotech Opportunities
Historical stock prices
Current Share Price	US$10.23
52 Week High	US$12.00
52 Week Low	US$9.71
Beta	0
1 Month Change	-0.29%
3 Month Change	0.69%
1 Year Change	4.71%
3 Year Change	n/a
5 Year Change	n/a
Change since IPO	6.56%

Recent updates

Shareholder Returns

	ORIA	US Capital Markets	US Market
7D	0%	-0.6%	-0.2%
1Y	4.7%	3.1%	14.8%

Return vs Industry: ORIA exceeded the US Capital Markets industry which returned 0.3% over the past year.

Return vs Market: ORIA matched the US Market which returned 4% over the past year.

Price Volatility

Is ORIA's price volatile compared to industry and market?
ORIA volatility
ORIA Average Weekly Movement	8.2%
Capital Markets Industry Average Movement	3.3%
Market Average Movement	6.9%
10% most volatile stocks in US Market	15.5%
10% least volatile stocks in US Market	2.9%

Stable Share Price: ORIA has not had significant price volatility in the past 3 months.

Volatility Over Time: ORIA's weekly volatility (8%) has been stable over the past year.

About the Company

Founded	Employees	CEO	Website
2021	n/a	Ruijin , James Huang	orionbiotechopportunities.com

Orion Biotech Opportunities Corp. does not have significant operations. It focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company intends to acquire businesses in the biotechnology and life sciences sectors.

Orion Biotech Opportunities Corp. Fundamentals Summary

How do Orion Biotech Opportunities's earnings and revenue compare to its market cap?
ORIA fundamental statistics
Market cap	US$255.75m
Earnings (TTM)	US$8.76m
Revenue (TTM)	n/a

29.2x

P/E Ratio

0.0x

P/S Ratio

Is ORIA overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
ORIA income statement (TTM)
Revenue	US$0
Cost of Revenue	US$0
Gross Profit	US$0
Other Expenses	-US$8.76m
Earnings	US$8.76m

Last Reported Earnings

Dec 31, 2022

Next Earnings Date

n/a

Earnings per share (EPS)	0.35
Gross Margin	0.00%
Net Profit Margin	0.00%
Debt/Equity Ratio	0%

How did ORIA perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2023/05/18 09:34
End of Day Share Price	2023/05/04 00:00
Earnings	2022/12/31
Annual Earnings	2022/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Orion Biotech Opportunities Corp. is covered by 0 analysts. of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Orion Biotech Opportunities Corp.OTCPK:ORIA Stock Report